These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia. Bishnoi M; Kumar A; Chopra K; Kulkarni SK Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557 [TBL] [Abstract][Full Text] [Related]
5. Role of serotonin in the action of atypical antipsychotic drugs. Meltzer HY Clin Neurosci; 1995; 3(2):64-75. PubMed ID: 7583621 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of clozapine versus other antipsychotics on clinical outcome and dopamine release in the brain. Advokat C Essent Psychopharmacol; 2005; 6(2):73-90. PubMed ID: 15765792 [TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
13. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents. Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931 [TBL] [Abstract][Full Text] [Related]
14. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia. Park WK; Jeong D; Cho H; Lee SJ; Cha MY; Pae AN; Choi KI; Koh HY; Kong JY Pharmacol Biochem Behav; 2005 Oct; 82(2):361-72. PubMed ID: 16216322 [TBL] [Abstract][Full Text] [Related]
15. [A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain]. Matsubara R Hokkaido Igaku Zasshi; 1993 Jul; 68(4):570-82. PubMed ID: 7687976 [TBL] [Abstract][Full Text] [Related]
16. Novel pharmacological approaches to the treatment of schizophrenia. Fink-Jensen A Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983 [TBL] [Abstract][Full Text] [Related]
17. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle. Ballmaier M; Zoli M; Mazzoncini R; Gennarelli M; Spano F Psychopharmacology (Berl); 2001 Dec; 159(1):105-10. PubMed ID: 11797077 [TBL] [Abstract][Full Text] [Related]
18. Effects of clozapine on cognitive function in schizophrenia. Lee MA; Thompson PA; Meltzer HY J Clin Psychiatry; 1994 Sep; 55 Suppl B():82-7. PubMed ID: 7961582 [TBL] [Abstract][Full Text] [Related]
19. Dopaminergic and serotonergic effects of clozapine. Implications for a unique clinical profile. Meltzer HY; Gudelsky GA Arzneimittelforschung; 1992 Feb; 42(2A):268-72. PubMed ID: 1586397 [TBL] [Abstract][Full Text] [Related]